Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keeton

Showing results (451-460 of 547) with videos related to

Pageof 55
Sort By:
Frontiers in Public Health|September 8, 2025
Precision public health alliances as a model and method for community engagementMargaret L McGladrey, Mary Elizabeth Lacy, Kristen McQuerry, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor modelsDaniela De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|January 13, 2024
Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS)Jonathan Rabner, Thomas M Olino, Anne Marie Albano, et al.
Journal of Consulting and Clinical Psychology|March 11, 2021
Impact of treatment improvement on long-term anxiety: Results from CAMS and CAMELSMargaret E Crane, Lesley A Norris, Hannah E Frank, et al.
Evidence-Based Practice in Child and Adolescent Mental Health|March 26, 2019
Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical PracticeAnne Marie Albano, Jonathan S Comer, Scott N Compton, et al.
Journal of Medicinal Chemistry|April 1, 2021
From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme SelectivityMohammad Abdel-Halim, Sara Sigler, Nora A S Racheed, et al.
Ambio|October 23, 2025
Pathways for Ukraine's post-war nature recovery: Focus on forest socio-ecological systemsMariana Melnykovych, Maria Nijnik, Oleksandr Soshenskyi, et al.
Journal of Consulting and Clinical Psychology|October 14, 2015
Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment StudyPhilip C Kendall, Colleen M Cummings, Marianne A Villabø, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffnessYanbin Dong, Inger S Stallmann-Jorgensen, Norman K Pollock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Limited role for lymphotoxin α in the host immune response to Mycobacterium tuberculosisNasiema Allie, Roanne Keeton, Nathalie Court, et al.
Pageof 55

Showing results (451-460 of 547) with videos related to

Sort By:
Pageof 55
Frontiers in Public Health|September 8, 2025
Precision public health alliances as a model and method for community engagementMargaret L McGladrey, Mary Elizabeth Lacy, Kristen McQuerry, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
Potency and selectivity of a novel pan-RAS inhibitor in 3D bioprinted organoid tumor modelsDaniela De Nobrega, Logan C Eiler, Parmanand Ahirwar, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|January 13, 2024
Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS)Jonathan Rabner, Thomas M Olino, Anne Marie Albano, et al.
Journal of Consulting and Clinical Psychology|March 11, 2021
Impact of treatment improvement on long-term anxiety: Results from CAMS and CAMELSMargaret E Crane, Lesley A Norris, Hannah E Frank, et al.
Evidence-Based Practice in Child and Adolescent Mental Health|March 26, 2019
Secondary Outcomes From the Child/Adolescent Anxiety Multimodal Study: Implications for Clinical PracticeAnne Marie Albano, Jonathan S Comer, Scott N Compton, et al.
Journal of Medicinal Chemistry|April 1, 2021
From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme SelectivityMohammad Abdel-Halim, Sara Sigler, Nora A S Racheed, et al.
Ambio|October 23, 2025
Pathways for Ukraine's post-war nature recovery: Focus on forest socio-ecological systemsMariana Melnykovych, Maria Nijnik, Oleksandr Soshenskyi, et al.
Journal of Consulting and Clinical Psychology|October 14, 2015
Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment StudyPhilip C Kendall, Colleen M Cummings, Marianne A Villabø, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffnessYanbin Dong, Inger S Stallmann-Jorgensen, Norman K Pollock, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2010
Limited role for lymphotoxin α in the host immune response to Mycobacterium tuberculosisNasiema Allie, Roanne Keeton, Nathalie Court, et al.
Pageof 55